I noticed people reading old articles on Inverse about Delta-8 and asked Emma Betuel to take a closer look at the cannabis subculture (this was one of the most-read features we published in 2021) inverse.com/science/delta-…

Sarah is an incredible writer, thoughtful editor and great storyteller!!! You want her writing on your site/in your mag!

Thrilled to back Gale Healthcare to ensure no person goes without care. Thanks to Emma Betuel for telling our story!

*JOURNALISTS!* it's a New Year. If you don't already write for Inverse and you have a track record of covering science, innovation, and health, then pls get in touch. We're looking to expand our roster of regulars. Email me (in bio). 🙏

Startup Battlefield Winner Cellino grabs $80M Series A tcrn.ch/3IvlTRo by Emma Betuel

Recently saw a job listing that counted writers as "non-technical" staff. So this hits for me today

thedailybeast.com/many-clinical-… One of the things I loved about this story: plenty of scientists see anxiety/emotional coping with the pandemic as an acute problem. Pandemic burnout is real and CBD could have a role to play

Incredible, heart wrenching reporting from Jack Crosbie. One of the few things I've read/watched today that grasps the, sad, real cost of this. rollingstone.com/politics/polit…

some ~ professional news ~ I'm moving on from covering biotech at TechCrunch to take on a new opportunity. I'll share what's next in a little bit, but anyone looking to pitch should direct those inquiries elsewhere for now!

Today's the day! Excited to join the content team NFX, where I'm helping create an essential content for early-stage founders.

Tech leaders, don't be afraid of building in biology. There’s plenty of space for tech entrepreneurs to come to bio and make an impact. We have the Ph.D.s and the science, but we also need you. NFX Bio's omri_drory has the guide: nfx.com/post/dont-be-a…

It’s been said already but SF’s AI energy is 🔥. Went to a meet up hosted by NFX yday. Lots of gen Zers eagerly showing app demos, VC said 6 friends moving back to sf because “they miss being around builders”, the first ever gen ai conference will be in sf on Valentine’s Day.

An interesting pair of graphs from NFX's latest survey. How 870 founders are thinking about their banking set up before/after SVB collapse. Nearly third still only have one bank account!

Attending AACR's Annual Meeting this week? Check out booths from NFX-backed C2i Genomics, Gilboa Therapeutics, Pepper Bio, Pangea Biomed, and resistanceBio, who are all developing novel approaches to defeating cancer, the 2nd leading cause of death in the US. #AACR23

A new wave of generative AI companies is already here. But they're invisible on market maps that over-index on incumbents. So we tapped our network to reveal the up & comers. Early-stage companies showing signs of future greatness. Meet the AI Hot 75. nfx.com/post/generativ…

Synthetic biology promises to stop viruses, create more resilient food sources, and improve human health. Congratulations to NFX's Gita Reinitz for being recognized as a leading female investor in the field in John Cumbers's article for Forbes. forbes.com/sites/johncumb…

too kind Riley Munks, also happy to chat or pass freelance contacts along to anyone. DMs open.